Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 270 results for "zydus group cadila healthcare"

Zydus gets USFDA nod to sell morphine sulfate tablets
DNA India

Cadila Healthcare gains after receiving market authorisation f...

Cadila Healthcare rose 1.29% to Rs 1,820 at 15:15 IST on BSE after the company said the Zydus group has received the market authorisation from the United States Food & Drug Administration to market Morphine Sulfate ER tablet. The company made announcement ... Business Standard, 4 weeks ago

Cadila Health up 3%, Zydus to market pain killer drug in US

Shares of Cadila Healthcare climbed 3 percent intraday Wednesday after the Zydus group allowed to market its strong pain killer drug in the US. "The Zydus group has received the market authorisation from the US Food and Drug Administration (USFDA) ...
 Moneycontrol.com4 weeks ago Cadila Healthcare up 3% on USFDA nod for neurological drug  Moneycontrol.com1 month ago

Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 crore

Mumbai: Cadila Healthcare, the Zydus Cadilla Group flagship, has emerged as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL) trumping several domestic and global peers who ...
 India Brand Equity Foundation2 months ago Cadila Healthcare eyes Claris arm for Rs 3,400 crore  Economic Times2 months ago Buy Cadila Healthcare; tgt of Rs 1920: Firstcall Research  Moneycontrol.com2 months ago Cadila Healthcare trumps peers, in talks to acquire Claris Lifesciences for whooping Rs 3,400 crore  Business Insider India2 months ago

Zydus to Present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patients With Type 2 Diabetes at the American Diabetes Association 75th Scientific Sessions in Boston, USA

/PRNewswire/ -- Zydus Cadila, a leading global healthcare provider, today announced that new scientific and clinical data on Saroglitazar will be presented at the 75th Annual Scientific Sessions of the American Diabetes Association (ADA) in ...
 Barchart1 month ago Zydus Cadila bets big on oncology  Times of India1 week ago

Cadila Healthcare to delist from Ahmedabad Stock Exchange, will remain listed on BSE and NSE

NEW DELHI: Cadila Healthcare has decided to delist its shares from Ahmedabad Stock Exchange (ASE) in view of non-trading of the company's shares on the exchange for past many years. The company's board, which met today, decided to delist equity ...
 Economic Times1 month ago Cadila to delist from Ahmedabad Stock Exchange  DeshGujarat1 month ago

Coal India, BS and Cadila Healthcare to see some action today

SENSEX 27802.00 35.21 0.13% NIFTY 8408.10 15.15 0.18% Industries: Airlines/Aviation, Metal and Mining, ...
 Finalaya.com2 months ago

Pieris Pharmaceuticals to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference

) - Pieris Pharmaceuticals, Inc . ( OTCQB: PIRS ), a biotechnology company advancing its proprietary Anticalin ® biotherapeutic technologies, announced today that President and CEO, Stephen Yoder, will present preclinical data on a new ...
 RCL Advisors2 months ago PIERIS PHARMACEUTICALS : to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference  4 Traders2 months ago Pieris Pharmaceuticals, Inc. (PIRS: OTCQB) | Pieris Pharmaceuticals to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference  OTC Markets2 months ago

The 5th Annual CFO100 Roll of Honour

CFO100 ROLL OF HONOR 2015 Cost Management Himanshu Agarwal Akzo Nobel India Limited Chief Financial Officer and Wholetime Director Sajal Gupta AMW Motors Limited Chief Financial Officer Anuj Aggarwal ...
 CFO India3 days ago

Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025

/PRNewswire/ -- Prospects for Development, Manufacturing and Business Expansion Sponsored by: Generic Drug Producers - Discover Top Companies' Revenue Prospects Now, Benefiting Your Influence What does the future hold for manufacturers and ...
 TickerTech.com3 days ago

Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2015-2025

/PRNewswire/ -- Biosimilar Drugs - Discover Revenue Potential Now, Benefiting Your Authority Do you want to fully understand the sales potentials for biosimilars ? This new analysis provides you with revenue forecasts to 2025 at overall world ...
 Sys-Con Media1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less